Zydus Lifesciences has informed that the Company has received an Assessment Order of FY 2017-18 on the issue pertaining to Input Tax Credit (‘ITC’). The details as required under regulation 30 of Listing Regulations read with SEBI Circular are enclosed.
The above information is a part of company’s filings submitted to BSE.